Reduced risk of cardiac disease and kidney disease Lowered blood pressure Delayed development of nephropathy, or diabetes-related kidney disease Also consider the financial benefits associated with GLP-1 injections
The forefront of diabetes medicine includes medicines targeting insulin production [2,3,4,5,6,7,8,9,10], such as semaglutide, a human incretin glucagon-like peptide-1 (GLP-1) receptor agonist, injected subcutaneously to increase insulin production [11], for weight loss in diabetic patients with obesity
How Retatrutide Works in the Body To understand what is retatrutide peptide, it is important to understand how it works inside the body
Marc Jean-Gilles, DO, FACOG , who will guide you through the process and help you start your treatment with confidence
When you stop taking GLP-1 medications suddenly, it can result in rapid weight regain
Oncology sales were $1.25 billion in 2021, with cell therapy sales of $871 million growing 43% compared with 2020 and Trodelvy sales of $380 million